α-SMA, alpha smooth muscle actin; DKK, Dickkopf ; ECM, extracellular matrix; FNH, focal nodular hyperplasia; FZD, frizzled; GSE, gene expression series; GSK3B, glycogen synthase kinase 3 beta; HCC, hepatocellular carcinoma; iPS cells, induced pluripotent stem cells, LEF1, lymphoid enhancer-binding factor 1; NT, non-tumor;
the aim of this study was to explore cancer cell phenotypes in fibrous nests.
Combined anatomic pathology, tissue microarray and real-time PCR analyses revealed that HCCs (n=82) containing fibrous nests were poorly differentiated, expressed Wnt pathway components and target genes, as well as markers of stem/progenitor cells, such as CD44, LGR5 and SOX9. Consistently, in severe liver fibroses (n=66) and in HCCs containing fibrous nests, weighted correlation analysis revealed a gene network including the myofibroblast marker ACTA2, the basement membrane components COL4A1 and LAMC1, the Wnt pathway members FZD1; FZD7; WNT2; LEF1; DKK1 and the Secreted Frizzled Related Proteins (SFRPs) 1; 2 and 5. Moreover, unbiased random survival forest analysis of a transcriptomic dataset of 247 HCC patients revealed high DKK1, COL4A1, SFRP1 and LAMC1 to be associated with advanced tumor staging as well as with bad overall and diseasefree survival. In vitro, these genes were upregulated in liver cancer stem/progenitor cells upon Wnt-induced mesenchymal commitment and myofibroblast differentiation.
In conclusion, fibrous nests express Wnt target genes, as well as markers of cancer stem cells and mesenchymal commitment. Fibrous nests embody the specific microenvironment of the cancer stem cell niche and can be detected by routine anatomic pathology analyses.
Introduction
The incidence of human hepatocellular carcinoma (HCC) has doubled over the past 20 years and projections anticipate a further increase despite recent breakthroughs leading to virological cure of chronic hepatitis (1) . More than 80% of HCCs arise in fibrotic livers as a result of HCV or HBV infections, alcohol, hemochromatosis, metabolic syndrome or genotoxins (2) . Recurrent bouts of liver cell damage and chronic inflammation result in progressive fibrosis and amplification of the stem cell niche (3) . Severe liver fibrosis is thus a pre-neoplastic condition at high risk of developing HCC (4) .
Molecular analysis of liver tissues in search for stem cells reveals a diversity of phenotypes(3) because the cells commonly observed under the microscope are "transit-amplifying stem cells" (3) . They are the progeny of stem cells that combine stem, hepatocyte and biliary cell markers. Some of the current molecular markers that help their identification are CD44, which is a hyaluronic acid receptor (5) ; LGR5, which is an R-spondin receptor that amplifies Wnt signaling (6) ; SOX9, which contributes to the Wnt-dependent maintenance of progenitor cells (7, 8) and, like EPCAM and KRT19, is expressed by multipotent ductal stem cells in normal liver (3) .
Except for KRT19, all of them are Wnt/β-catenin target genes. This further highlights the importance of Wnt signaling in stem cell control (9) . EPCAM and KRT19 label bipotent progenitor cells with an intermediate phenotype between hepatocytes and bile duct cells and identify malignant bile duct cell components in combined hepatocellular-cholangiocarcinoma, which is a particularly aggressive form of liver cancer (10, 11) . Other molecules highlight mesenchyme-committed progenitor cells, such as IGFBP5, which is a Wnt/β-catenin pathway target gene involved in mesenchymal commitment of stem cells (12) . Along these lines, we recently showed 8 that Wnt signals reprogram tumorigenic liver progenitor cells to replicating fibrogenic myofibroblast-like cells displaying stem and invasive features and expressing the stem cell markers IGFBP5, LEF1, CD44 and LGR5 (13) .
The activation of the Wnt/β-catenin pathway involves interaction of Wnt ligands with cell surface Frizzled (FZD) receptors and LRP5/6 co-receptors, followed by disruption of the Adenomatous polyposis coli (APC)-axin platform, which blocks GSK3Bdependent phosphorylation of β-catenin. Non-phosphorylated β-catenin is thus stabilized, accumulates in the cytoplasm and nucleus and interacts with the family of T-cell factor (TCF)/lymphoid enhancer factor (LEF) transcription factors of target gene expression. As LEF1 is a β-catenin target gene, it leads to cell autonomous pathway activation (14) . At the opposite, in the absence of interaction of Wnt ligands with their cell surface receptors, phosphorylated β-catenin undergoes proteasomal degradation (15) .
Wnt signaling is regulated at the cell surface by extracellular modulators, including the Secreted Frizzled Related Protein (SFRPs) and Dickkopf (DKK) families, Wnt Inhibitory Factor-1 (WIF-1) and the ZNRF3 and RNF43 transmembrane E3 ubiquitin ligases (16) . SFRPs are soluble molecules that possess a Frizzled Cysteine-Rich Domain (FZD_CRD), structurally homologous to the Wnt-binding domain of the FZD receptors (17) . They also possess a netrin domain (17) . Through their FZD_CRD, not only can SFRPs bind Wnts, but also they may directly signal by forming heterodimers with the CRD of the FZD receptors (17) . Through their netrin domain, they bind heparan sulfates (17, 18) . SFRPs and SFRP-like proteins are short-range modulators of Wnt signals, i.e., secreted at low levels at the cell surface, they exert their effects upon nearest-neighbor cells, as we previously showed by co-culture experiments (19, 20) . At low concentrations, SFRPs mask the hydrophobic domains of Wnts, 9 increasing their diffusion at the cell surface, thereby promoting Wnt signaling. At high concentration, they block Wnt-FZD receptor interactions (18) . Thus, SFRPs may either promote or inhibit Wnt signaling depending on concentration, FZD receptor context and the composition of the cell surface microenvironment (18) . DKKs bind the Wnt co-receptors LRP5/6, blocking the formation of ternary LRP-FZD-Wnt complexes to inhibit Wnt signaling (16) . Last, the transmembrane ubiquitin ligases ZNRF3 and RNF43 promote endocytosis and degradation of FZD receptors from the cell surface.
In turn, these ubiquitin ligases are inhibited by R-spondin binding to LGR5 receptors (16) .
Among the ECM of components of HCCs, COL4A1 and LAMC1 are major basement membrane proteins upregulated in angiogenesis and cancer extracellular matrix remodeling (21) (22) (23) . Of note, LAMC1 expression is modulated by Wnt signaling(24).
Although HCCs are soft cellular tumors with scant intratumor fibrosis (25) , they may contain fibrous hotspots within the tumor mass, which we called fibrous nests. The aim of this work was to study the cancer cell phenotypes in fibrous nests in HCC.
Tumors containing fibrous nests revealed a gene expression network composed of cancer stem cell markers, cell surface Wnt components and Wnt/β-catenin target genes that correlated with myofibroblast and basement membrane markers.
Unbiased validation of our data in an external 247 HCC patient cohort revealed a minimal bad outcome signature in HCCs. This minimal signature was in turn upregulated upon reprogramming of liver cancer stem/progenitor cells into fibrogenic, myofibroblast-like cells by soluble Wnt ligands in vitro. The findings suggest that a Wnt-enriched cancer cell microenvironment contributes to tumor dedifferentiation and aggressiveness.
Materials and Methods

Real-time PCR primers and antibodies
See Supplementary Table 1 for real-time PCR primers and TaqMan probes and Supplementary Table 2 for antibodies. Supplementary Table 3 . We also included 66 matching non-tumor livers, 23 histologically normal livers and 11 focal nodular hyperplasias. Non-tumor and normal liver samples were obtained at >2 cm from the tumors to minimize non-specific events, as described (26) . Frozen samples were from the Biological Resources Center (BRC) at Rennes University Hospital (BB-0033-00056). Fresh tissues were frozen at -80°C in N 2 -cooled isopentane and stored at -80°C under quality-controlled conditions. Formalin-fixed, paraffin-embedded tissue blocks were obtained from the 
Patients and tissue samples
Functional Genomics Analyses
Gene networks were generated by Weighted Correlation Network Analysis (WGCNA, WGCNA package)(27) using real-time PCR mRNA expression data from the indicated patient groups, after removing the experimental batch effect with the SVA package (28) . Gene networks were visually integrated with Cytoscape, with a correlation coefficient threshold >0.30 (29) . Genomics analysis using microarraybased raw gene expression data downloaded from Gene Expression Omnibus were background corrected and log 2 intensity summary values for each probe set were calculated using Robust Multi Array Average (Affy package). Probes were further prefiltered using a p-value detection threshold (p<0.05) in all samples. When multiple probe sets mapped a unique gene, we used the probe with a p-value detection <0.05 in most samples. Finally, data were quantile normalized (preprocessCore package) and hierarchical clustering was performed with the hclust function in R software, applying the Ward method to correlation-based distances. Gene set enrichment analysis (GSEA) was performed with the web-based tool developed at the Broad Institute (30) .
Statistical Analyses
Raw feature data from Gene Expression Omnibus were background corrected and log2 intensity expression summary values for each probe set were calculated using the Robust Multiarray Average package (RMA, Affymetrix). Probes were further prefiltered using P-value (<5% in all samples). When multiple probe sets mapped a unique gene, we used the probe with a p-value detection<0.05 in most samples. For 12 survival analyses, non-tumor and normal tissue samples were excluded from the analysis. We then generated a transcriptomic signature associated with disease-free survival measured by a Recurrence Index (RI). To this end, we applied the Random Survival Forest (RSF) method (RandomForestSRC package). RSF is a method for prediction and variable selection for right-censored survival by growing a high number of decision trees after bootstrap subsampling (31) . A Cumulative hazard function (CHF) was calculated for each individual and used to estimate the RI. Input variables were the 17 genes analyzed throughout this study. Serum alpha-fetoprotein (with a cutoff over 300ng/ml) was also integrated for variable selection. The events to predict by RSF were the disease-free survival status at each time. Variable importance (VIMP) scores were computed for all the variables used to grow the trees, and the most informative from this model were selected to fit a new RSF model.
Once the model was built, we tested whether selected variables were redundant or "noisy" by generating incremental RSF models adding one more variable, ranked by the VIMP calculated in the previous model. The final model was used to generate a RI score for each individual. RI scores were computed as the sum of the CHF for each patient weighted by the number of individuals at risk at distinct time points.
Survival analyses were performed using the Log Rank test and Kaplan-Meier curves. Heatmaps showing associations between binary patient data were constructed with 13 Excel (Microsoft Office 2010). Statistical calculations were performed with the R software (version 3.1.1) and the packages survival, colorspace, made4 and marray or with Statistica 10 (Statsoft, Maisons-Alfort, France).
Correlation analyses between gene expression levels were performed with the
For cell culture and clonogenesis assay, nucleic acid extraction, real-time PCR, tissue microarray (TMA) and immunohistochemistry scoring of human tissues, see Supplementary Materials and Methods. 14 
RESULTS
Tumors containing fibrous nests are less differentiated, enriched in Wnt/βcatenin pathway components and stem/progenitor cell markers
To study the molecular features of HCCs containing fibrous nests, we reviewed were not associated with intratumor fibrosis (Fig. 1B) . Fibrous hotspots expressed alpha smooth muscle actin (ACTA2), indicating that fibrous nests were enriched in myofibroblasts ( Fig. 1D ). 15 We then studied the relationships between the liver progenitor cell markers KRT19, EPCAM, LGR5, SOX9 and GPC3. We chose GPC3 because it is a wellcharacterized tumor hepatocyte marker and a cell surface heparan sulfate proteoglycan(33, 34) that binds Wnts and FZD receptors, amplifying Wnt signals (34) .
As expected(7, 10), KRT19 was highly correlated with EPCAM ( Fig. 2A) , and both were weakly correlated with SOX9. CD44 was correlated with LGR5, as well as with SOX9 and GPC3. Associations between these markers were more easily pinpointed by in situ protein analysis of fibrous hotspots, rather than by solution-based mRNA analysis of whole frozen tissue blocks. These data are consistent with the notion that "fibrous nests" are localized entities, where tumor cells expressing stem/progenitor markers may be found at higher densities.
Then, we split the HCC population in two subsets: low and high tumor fibrosis, using a cutoff score ≥2. HCCs with high tumor fibrosis showed higher mRNA and protein levels of CD44; GPC3 and SOX9 (Fig. 2 , B-D). LEF1 (analyzed at the mRNA level only) was also higher in HCCs with high fibrosis scores ( Fig. 2E ). By contrast, LGR5 was only associated with high fibrosis scores by immunohistochemistry ( Fig. 2F ).
Taken together, these findings suggested that HCCs containing fibrous nests were enriched in Wnt/β-catenin pathway target genes and such as CD44, SOX9, LEF1, SFRP2 and LGR5 (Fig. 1B , C and 2B, D-F). Some of them are also stem/progenitor cell markers, such as CD44, IGFBP5, SOX9 and LGR5 (Fig. 1B , C and 2B, D-F).
Myofibroblast activation is associated with tumor fibrosis and with the expression
of cell surface Wnt pathway and basement membrane components. 16 We were surprised to find an association of SFRP2 and 5 with tumor fibrosis ( Fig. 1B) , because SFRPs are frequently downregulated in cancers (35) . To confirm this finding, we searched for correlations between SFRPs and smooth muscle actin (ACTA2), which is a myofibroblast activation marker. High mRNA levels of ACTA2 were associated with high scores of fibrosis in 78 HCCs (Fig. 3A) . In non-tumor livers, fibrosis was graded by the METAVIR score (36) . Out of 66 available non-tumor samples, 62 (92%) showed severe fibrosis, i.e., scores ≥3 (Supplementary Table 3 ).
In these samples, SFRP1; 2 and 5 and, in HCCs with high tumor fibrosis, SFRP1 and 2 correlated with ACTA2 ( Fig. 3B ). Consistently, Fig. 3C shows that SFRP1; 2 and 5 were higher in HCCs expressing high ACTA2 levels. We thus asked whether other Wnt pathway components were associated with myofibroblast activation in HCCs.
High levels of the basement membrane components COL4A1 and LAMC1 were associated with ACTA2. In addition, DKK1; FZD1; FZD7; WNT2 and LEF1 were increased in HCCs expressing high ACTA2 levels. By contrast, WNT3; KRT19 and EPCAM were not associated with ACTA2. Taken together, these data suggest that myofibroblast activation is associated with the expression of cell surface Wnt pathway components.
SFRP1; 2 and 5 are expressed by mesenchyme-committed cancer stem/progenitor cells.
Cancer-associated myofibroblast-like cells may either originate from stromal cell recruitment or from cancer cell dedifferentiation and epithelial-mesenchymal transition (EMT) (37, 38) . We thus asked whether SFRP expression was a general theme in mesenchymal lineage commitment. To achieve a general overview, we 17 studied five cellular models involving mesenchymal commitment and/or myofibroblast differentiation. First, we analyzed the GSE49910 microarray dataset gathering 745 primary cell samples (39) . To identify the cell lineages expressing the highest levels of SFRPs, we set the cutoff at >0.91 centile for SFRPs 1 and 2 and >0.5 centile for SFRP5 ( Fig. 4A and Supplementary Fig. 1A ). Consistently with our in vivo findings, SFRP1 was mainly expressed by smooth muscle cells, stem cell-derived neural precursors, stem cells, Schwann cells and fibroblasts (Fig. 4A ). SFRP2 was mainly expressed by stem cells and NCAM(+)/EPCAM(+) mesodermal progenitors (Fig. 4A) , which represent the first stages of mesoderm commitment of undifferentiated human embryonic stem cells (40) . In turn, SFRP5 ( Supplementary Fig. 1A ) was predominantly expressed by cells of mesodermal origin, except for Schwann cells and keratinocytes (ectodermal origin). Particularly, the highest levels of SFRP5 were detected in mesenchymal stromal cells undergoing osteoblast differentiation.
Second, a convenient model to study cell plasticity is the generation of hepatocytelike cells from fibroblast-derived undifferentiated iPS cells(41) (Fig. 4B ). In this model, SFRP1 and 2 were preferentially expressed by undifferentiated iPS cells, their expression dramatically decreasing upon hepatocyte differentiation (Fig. 4B ). By contrast, SFRP5 was detected at low levels in fibroblast-derived undifferentiated iPS cells ( Supplementary Fig. 1B ).
Third, we recently showed that soluble Wnt signals reprogram liver progenitor cells to replicating fibrogenic myofibroblast-like cells with stem and invasive features (13) .
Consistently, we confirm here that reprogramming liver progenitors with 200 ng/ml Wnt3a induces a dramatic fall in albumin expression by hepatocyte-like cells, shifting the cell phenotype toward myofibroblast-like cells expressing ACTA2, COL4A1, 18 LAMC1 ( Fig. 4C) , as well as SFRP1 and DKK1, with a considerable decrease in the epithelial cell marker E-cadherin ( Fig. 4D) .
Fourth, cancer cells can dedifferentiate to stem/progenitor cells through transient EMT, which fosters tissue invasion, cell proliferation and tumor aggressiveness (38) .
To study the involvement of SFRPs in this process, we used HepaRG progenitor cells (38, 42) , which are derived from a human HCC (43) . Like 60% HCCs, they contain a TERT mutation (44) , can be tumorigenic in mice (45) , but have wild-type βcatenin pathway components (42) . HepaRG progenitor cells differentiate into hepatocyte-like and biliary-like cells when grown at confluency for 30 days (42) . When these differentiated HepaRG cells are split and seeded at low density, they express TWIST1 and SNAI1 transcription factors, undergo EMT, dedifferentiate to liver progenitors displaying mesenchymal features (fusiform morphology, expression of mesenchymal markers such as vimentin and ECM proteins) and express an mRNA signature of high tumor aggressiveness four days after seeding (38) . Thus, four days after seeding differentiated HepaGR cells at low density, we observed high expression of SFRP1 and 2, which gradually decreased over 30 days, along mesenchymal to epithelial transition (MET) and hepatocyte differentiation ( Fig. 5A ). Fig. 3B ) and not modulated along hepatocyte differentiation (not shown). SFRP1 and 2 expression kinetics matched those of LGR5(6) and the fibroblast marker COL1A1 ( Fig. 5A ). It was opposite to the kinetics of the hepatocyte differentiation marker ALDOB (Fig. 5A) . These data indicate that SFRP1 and 2 are upregulated during EMT. Conversely, their expression falls during MET in liver cancer cells.
Of note, SFRP5 was expressed at very low levels in HepaRG cells (Supplementary
Fifth, to further explore cell plasticity, we used the 3P/3SP model of spontaneous EMT in human HCC (46) . Both cell lines derive from the same HCC, 3SP resulting 19 from 3P cells that underwent spontaneous EMT (46) . Thus, using publically available transcriptomic data from 3P and 3SP cell lines, we found that the genes associated with fibrous nests and/or myofibroblast activation were expressed at higher levels in mesenchymal 3SP than in epithelial 3P cells ( Fig. 5B ). Of note, epithelial 3P cells expressed higher levels of the tumor hepatocyte marker GPC3(33) and the epithelial stem cell marker LGR5(6) than 3SP cells. In addition, although GPC3 and LGR5
were associated with fibrous nests in HCCs, they were not associated with high ACTA2 expression. This is explained by the topography of LGR5 and GPC3 expressing cells. As shown in Fig. 1D, LGR5 and GPC3 were expressed by nodules of epithelial tumor cells. Moreover, we have previously shown that LGR5-expressing cells are seen both in epithelial tumor nodules and as single rows of cancer cells invading the tumor stroma, in an "Indian file" pattern, interspersed along the axis of ECM fibers (13) . Further confirming our findings in HCCs, unbiased Gene Set Enrichment Analysis (GSEA) revealed that the top 20% of mRNA signatures matching the transcriptome of mesenchymal 3SP cells included Wnt/β-catenin signaling, stem cells, extracellular matrix remodeling, TGFB signaling, bad outcome in cancer and resistance to anti-cancer treatments. Importantly, these stem cell signatures matched those of aggressive non-hepatic cancers, indicating that mesenchyme-committed liver cancer cells are highly undifferentiated ( Fig. 5C and Supplementary Table 4 ).
Cell surface Wnt pathway components network with the myofibroblast activation marker alpha smooth muscle actin (ACTA2) and with the basement membrane components collagen type IV (COL4A1) and laminin ɣ1 (LAMC1) in severe liver
fibrosis and in HCCs with high tumor fibrosis. 20 SFRPs are soluble tissue morphogens that bind the cell surface matrix, thus creating short range concentration gradients spanning only a few cells (35) . In normal liver, SFRPs 1 to 5 mRNAs were expressed at low levels ( Supplementary Fig. 2 ). In eight HCC and two colorectal cancer cell lines, SFRP1 and 5 were dramatically lower than in normal liver ( Supplementary Fig. 3, A and B) and restoring SFRP1 and SFRP5 in the Huh-7 HCC cell line decreased clonogenesis ( Supplementary Fig. 3, C and D) .
The Huh-7 cell line carries wild-type Wnt/β-catenin pathway components (47) , but shows active β-catenin as a result of an increase in Wnt ligands and SFRP promoter methylation(48, 49). Likewise, we (19, 20, 50) and others(51) have shown that SFRP1 blocks Wnt/β-catenin signaling and tumor growth in cells carrying β-catenin exon 3 mutations, including the hepatoblastoma cell line HepG2 (50) .
The increase in SFRPs 1; 2 and 5 in HCCs showing myofibroblast activation was difficult to reconcile with the dramatic downregulation of SFRPs in cancers (35) . To understand this paradox, we analyzed 82 HCCs, 66 matching non-tumor livers, 23 histologically normal liver controls and 11 focal nodular hyperplasias (FNH). FNHs are benign liver tumors that display features of the stem cell niche, particularly rich in transit-amplifying liver cell progenitors and extracellular matrix remodeling, without the potential for tissue destruction of cancer (3, 52) . Supplementary Fig. 4 shows mRNA expression analysis confirming downregulation of SFRP1(48) and upregulation of WNT3(53) in HCCs. SFRP5 was downregulated as well. As SFRPs 1 and 5 were lower by several folds in HCCs than in normal liver controls, matching non-tumor livers and FNHs, this downregulation appears to be cancer-specific and could help the diagnosis of HCCs. By contrast, WNT3, FZD1 and FZD7 were higher in HCCs, non-tumor livers and FNHs than in controls. COL4A1 was expressed at higher levels in HCCs, non-tumor livers and FNHs than in controls. 21 Supplementary Fig. 5 shows that SFRP2, ACTA2, WNT2 and LAMC1 were not significantly different in HCCs from controls or non-tumor samples, but that DKK1 was expressed at higher levels in HCCs than in controls.. Ninety-two percent of non-tumor livers in this series showed high fibrosis (61 out of 66 with METAVIR score ≥3; Supplementary Table 3 ). In these samples, COL4A1, LAMC1 and ACTA2, were correlated with all the Wnt pathway components tested but Wnt3 ( Supplementary Table 5A ). In 82 HCCs, COL4A1, LAMC1 and ACTA2 were correlated with SFRPs 1 and 2. The correlation of ACTA2 with SFRPs 1 and 2 and of COL4A1 with SFRP1 was only seen in HCCs with high tumor fibrosis.
We then applied Weighted Correlation Network Analysis (27, 29) that revealed associations of ECM remodeling and Wnt pathway components, particularly in liver fibrosis and in HCCs with high tumor fibrosis, but not in HCCs with low tumor fibrosis ( Fig. 6) . These data indicate that despite the dramatic decrease in SFRP1 and SFRP5 expression in HCCs, these SFRPs (within a low-level expression range), as well as other cell surface Wnt pathway components (i.e., WNT2, DKK1, FZD7 or FZD1) were associated with the basement membrane components COL4A1 and LAMC1 and with the myofibroblast activation marker ACTA2. We have previously shown that COL4A1 expression is correlated with the mRNA expression of the ECM remodeling enzymes MMP2 and MMP14 and with MMP2 enzymatic activity (54) .
Reanalysis of the available unpublished data from that report involving 47 human
HCCs confirmed that this was also the case for LAMC1 ( Supplementary Table 5B ).
Taken together, these findings suggest that the microenvironment of fibrous nests brings together myofibroblast activation, expression of basement membrane components and cell surface Wnt signals. 22 
A minimal Wnt & extracellular matrix signature is associated with tumor recurrence and ominous clinical features in patients with HCC.
Using the 17 genes analyzed in this study, we applied the unbiased random survival forest (RSF) method to generate a minimal signature associated with patient outcome. To this end, we analyzed a public dataset including whole genome tumor tissue mRNA expression data (GSE14520) and clinical annotations (Supplementary Table 6 ) from 247 patients with HCC treated by surgical resection (55) . Serum alphafetoprotein >300 ng/ml was also included in variable selection. The events to predict were the disease-free survival status at each time point. The final model yielded four variables: DKK1; COL4A1; SFRP1 and LAMC1 and was used to generate a recurrence risk index (RI; range, 17-132) for each individual. Using the centile 0.75 of this index (RI>62), we split the 247-patient dataset in high and low risk groups. Fig. 7 shows that the high risk group had lower disease-free and overall survival rates over a 5-year follow-up. Clinical features of patients with high RI were: advanced tumor staging, HCCs arising at a younger age, high serum alpha fetoprotein levels and high incidence of the Metastasis Signature (Fig. 7 , C, D and Supplementary Table 7 ). The Metastasis Signature(55) is a 161-gene risk classifier enabling prediction of tumor relapse in early-stage HCC patients. Clinical features not associated with high RI are shown in Supplementary Table 7 . In addition, high mRNA levels of FZD7; COL4A1; LAMC1; DKK1; SOX9; GPC3 and LEF1 were associated with clinical features announcing bad HCC outcome ( Supplementary Table 8 ). 23 
DISCUSSION
We found that tumors containing fibrous nests were less differentiated and expressed Wnt pathway components and target genes as well as stem/progenitor cell markers.
Tissue microarray-based immunohistochemistry analysis of tissue carrots directly punched from fibrous nests in formalin-fixed paraffin-embedded HCC tissues revealed GPC3 (+) HCC cells expressing the tumor stem/progenitor cell markers CD44, LGR5 and SOX9. By contrast, neither KRT19 nor EPCAM were associated with fibrous nests, probably because combined hepatocellular-cholangiocarcinomas were excluded from our study. Similarly, a previous work found that the association of KRT19 with fibrous stroma was cohort-dependent (56) . GPC3 (34) and LGR5(57) are both cell surface enhancers of Wnt signaling. GPC3 is specific of tumor hepatocytes and is used in routine diagnosis of HCC, with a 77% sensitivity(33). LGR5 hallmarks Wnt-driven amplification of liver progenitors (57) . In addition, we found other molecules associated with fibrous nests and/or myofibroblast activation, such as LAMC1, COL4A1, SFRP1; DKK1; FZDs 1 and 7; WNT2, IGFBP5 and LEF1. Downregulation of SFRP expression by promoter methylation is a common theme in most human cancers, including HCCs (35, 49, 58) . Conversely, ectopic expression of SFRP1 (48, 51) and SFRP5 (this work) decreases tumor cell growth. By contrast, a recent methylome profiling of 304 HCCs did not confirm SFRP promoter methylation among the top-100-ranked probes, the frequency of SFRP5 methylation in HCCs being of only 3 %(59). As SFRP1 and 5 were by several folds lower in HCCs than in non-tumor livers, other mechanisms of SFRP downregulation in HCC should be explored. Whatever the case, two lessons were drawn from our findings. First, in contrast with FZDs 1; 7 and WNT3, which were upregulated in both tumor and nontumor samples, the fall in SFRPs 1 and 5 was HCC-specific. Second, in HCCs, 24 SFRP1 was associated with myofibroblast activation. We confirmed these findings by five different cell biology approaches, including Wnt-induced differentiation of liver progenitor cells into fibrogenic myofibroblast-like cells, which upregulated SFRP1 expression. Consistently, SFRP1 favors amplification of mesenchymal stem cells in muscular dystrophy (60) and induces matrix metalloproteinase expression and pulmonary fibrosis (61) . In addition, direct interaction of SFRP1 with the FZD2 receptor modulates axon growth, the final output depending on the fibronectin/laminin balance in the ECM (17) .
We recently showed that soluble Wnt signals reprogram liver cancer progenitor cells into myofibroblast-like cells (13) . In this context, we confirmed that Wnt-induced myofibroblast-like cells upregulate the expression of DKK1, COL4A1, SFRP1 and LAMC1. In 247 HCC patients, these four genes were associated with bad diseasefree and overall outcome as well as with advanced tumor staging, high alphafetoprotein levels and a 161-gene signature predicting tumor relapse. Furthermore, seven genes upregulated in fibrous nests and/or in HCCs with myofibroblast activation were associated with bad outcome predictors ( Supplementary Table 8 ).
These included FZD7 and DKK1, which are markers of Wnt/β-catenin activation in HCCs (62) (63) (64) . DKK1 is a Wnt pathway inhibitor, which expression is induced by active β-catenin. It is thus involved in a negative feedback loop that controls Wnt pathway activation in normal cells (65) . However, in some cancer types, high DKK1 reflects active Wnt/β-catenin signaling (64, 66) . Particularly, DKK1 is a diagnostic biomarker of HCC (67) . In turn, WNT2, which is secreted by fibroblasts, activates Wnt signaling and tumor progression in oesophageal cancer (68) , and is associated with the differentiation of pancreatic stellate cells to myofibroblasts in chronic pancreatitis (69) . In the liver, WNT2 is secreted by sinusoidal endothelial cells and, 25 like LGR5, contributes to the stem cell niche for hepatocyte regeneration after injury (6, 57, 70, 71) . Altogether, these findings indicate that tumor fibrous hotspots are contingent with upregulated expression of cell surface Wnt components and target genes, myofibroblast activation and undifferentiated cancer stem cell markers. These elements come together within a specific, topographically defined tumor microenvironment that we called fibrous nests. This term conveys the notion of cell surface signals nurturing tumor growth and associates the cancer stem cell niche with tumor tissue structures detectable by routine anatomic pathology analyses. Statistically significant correlations are highlighted in red. (C) ACTA2 mRNA levels in HCCs were split into High (n=20) and Low (n=58) groups (cutoff = median). SFRP1; 28 2 and 5; the extracellular matrix components COL4A1 and LAMC1; the Wnt inhibitor DKK1; the Wnt cell surface receptors FZD1 and FZD7; the WNT2 ligand, the mesenchymal cell marker IGFBP5 and the β-catenin pathway transcription factor LEF1 are associated with high levels of ACTA2 expression. Networks with a correlation coefficient threshold >0.30 were visually integrated with Cytoscape (29) . Closeness between nodes is proportional to the number of connections. Thickness of links is proportional to the correlation coefficients between genes. Correlation coefficients are shown in Supplementary Table 5A . 
Figure legends
